Skip to Content
Home | news | Health Care

Health Care

Carter pens letter calling for Taiwan to join the WHO

| Posted in Press Releases

WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) led a letter, signed by 15 Members of the GOP Doctors Caucus, to World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus today advocating for Taiwan’s inclusion in the organization. The WHO’s continued exclusion of Taiwan is a kowtow to the Chinese Communist Party, who refuse to acknowledge Taiwan as the independent nation t...

Carter recognizes National Fentanyl Awareness Day

| Posted in Press Releases

WASHINGTON, D.C. – Today is the first annual National Fentanyl Awareness Day. Rep Earl L. “Buddy” Carter (R-GA), a pharmacist by trade, is educating families about the dangers of this lethal drug. “Fentanyl overdoses are at an all-time high. This drug, often disguised as a simple painkiller, is ravaging our communities,” said Carter. “As a pharmacist, I am calling on the public to never take a pil...

Carter leads bills to lower drug costs in E&C FDA Package

| Posted in Press Releases

WASHINGTON, D.C. – The Energy and Commerce Committee unveiled its bipartisan package to reauthorize the Food and Drug Administration (FDA) User Fee Agreements. The package, introduced by Health Subcommittee Republican Leader Brett Guthrie (R-KY) and Health Subcommittee Chairwoman Anna G. Eshoo (D-CA), includes four provisions led by Rep. Earl L. “Buddy” Carter (R-GA) that would lower drug costs, m...

At Carter’s urging, FTC Chair acknowledges dangers of PBMs

| Posted in Press Releases

WASHINGTON, D.C. – Since day one in Congress, Rep. Earl L. “Buddy” Carter (R-GA) has been sounding the alarm on the predatory practices of the pharmaceutical industry’s middlemen, pharmacy benefit managers (PBMs). Following Rep. Carter’s March, 2022 call with Federal Trade Commission (FTC) Chair Lina Khan, she publicly agreed that PBMs reduce patient’s access to life-saving drugs. “Finally, the FT...

Reps. Carter, Kind, McKinley, and Barragán Introduce the Bipartisan Equitable Community Access to Pharmacist Services Act

| Posted in Press Releases

WASHINGTON, D.C. – Today, Rep. Earl L. "Buddy" Carter (R-GA) joined Reps. Ron Kind (D-WI), David B. McKinley (R-WV), and Nanette Diaz Barragán (D-CA) in introducing the bipartisan Equitable Community Access to Pharmacist Services Act. This legislation will help ensure patients can continue to access COVID-19 pandemic and pandemic-related health services from pharmacists and provide pharmacists wit...

Carter leads House Republican rebuke of HHS’ abortion agenda

| Posted in Press Releases

WASHINGTON, D.C. – The U.S. Department of Health and Human Services (HHS) formed a pro-abortion task force to dismantle state governments’ work to protect unborn lives. Rep. Earl L. “Buddy” Carter (R-GA) led a letter, cosigned by 53 House Republicans, to Secretary Xavier Becerra expressing concern that his mislabeled Task Force on Reproductive Healthcare Access endangers the lives of innocent chil...

Carter moves to expedite generic drug approval process

| Posted in Press Releases

WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) introduced legislation that will speed up the FDA’s approval process for affordable alternatives to brand name drugs. The Enhanced Access to Affordable Medicines Act of 2022 will save the health care system millions and increase access to generic medications. “We need to cut the red tape that delays patient access to life-saving medications. Th...

ICYMI: Major win for patients in No Surprises Act ruling

| Posted in Press Releases

WASHINGTON, D.C. – A federal judge struck down portions of the Biden Administration’s regulations implementing the bipartisan No Surprises Act. This bill represents a multi-year commitment to increasing the affordability of health care by eliminating surprise medical bills from out-of-network providers. The Biden Administration’s implementation of the legislation expressly ignored legislative inte...

FDA drops plan that would reduce patient access to compounded drugs

| Posted in Press Releases

WASHINGTON, D.C. – Following Republican and stakeholder opposition, the federal government dropped its plan that would have restricted patients’ access to lifesaving medications. The Food and Drug Administration (FDA) announced today that it is rescinding a controversial memorandum of understanding (MOU) requiring states to either adopt a burdensome, poorly crafted policy targeting drug compounder...

Carter on SCOTUS split vaccine mandate decisions

| Posted in Press Releases

WASHINGTON, D.C. – The Supreme Court of the United States (Court) today struck down the Biden Administration’s unconstitutional vaccine mandate for private employers but declined to offer those same protections to health care workers. Rep. Earl L. “Buddy” Carter (R-GA) gave the following statement responding to today’s mixed decision: “The federal government has no business dictating private medic...